Aurinia Pharmaceuticals (AUPH)
(Delayed Data from NSDQ)
$7.26 USD
+0.35 (5.07%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $7.28 +0.02 (0.28%) 6:00 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.26 USD
+0.35 (5.07%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $7.28 +0.02 (0.28%) 6:00 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Zacks News
What's in the Cards for Repros (RPRX) this Earnings Season?
by Zacks Equity Research
Repros Therapeutics Inc. (RPRX) is expected to report first-quarter 2017 results this month. Let's see how things are shaping up for this quarter.
Will Intrexon (XON) Pull Off a Surprise in Q1 Earnings?
by Zacks Equity Research
Intrexon Corporation (XON) is expected to report first-quarter 2017 results on May 9.
Implied Volatility Surging for Aurinia Pharmaceuticals(AUPH) Stock Options
by Zacks Equity Research
Implied Volatility Surging for Aurinia Pharmaceuticals(AUPH) Stock makes it lucrative to the option traders.
Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock?
by Anupriya Datta
Investors in Aurinia Pharmaceuticals Inc. (AUPH) need to pay close attention to the stock based on moves in the options market lately.
Aurinia (AUPH) Catches Eye: Stock Moves up 8.5% in Session
by Zacks Equity Research
Aurinia Pharmaceuticals Inc. (AUPH) moved big last session, as its shares rose above 8% on the day.
Aurinia Pharmaceuticals (AUPH) Shares March Higher, Can It Continue?
by Zacks Equity Research
Aurinia Pharmaceuticals Inc. (AUPH) has been on the move lately as the stock has risen by 41.8% in the past four weeks, and it is currently trading well above its 20-Day SMA
Can The Uptrend Continue for Aurinia Pharmaceuticals (AUPH)?
by Zacks Equity Research
Investors certainly have to be happy with Aurinia Pharmaceuticals Inc. (AUPH) and its short term performance
Aurinia Pharmaceuticals (AUPH) Jumps: Stock Rises 5.6%
by Zacks Equity Research
Aurinia Pharmaceuticals Inc. (AUPH) moved big last session, as its shares jumped almost 6% on the day.
Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options
by Zacks Equity Research
Investors in Aurinia Pharmaceuticals Inc. (AUPH) need to pay close attention to the stock based on moves in the options market lately.